Panadea

We are a Germany-based biotechnology company, located in Hamburg, with a keen focus on the provision of top quality tests for tropical and emerging infectious diseases.
‍
Leveraging our patented technology platform, our immunoassay tests have superior specificity and sensitivity, especially targeting the priority diseases in the WHO blueprint list. The outstanding performance characteristics of our tests have proven that we are providing the best tools for scientists, researchers and health authorities for their tasks of outbreak monitoring, infection surveillance, and seroprevalence studies.